Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0000899243-19-025494
Filing Date
2019-10-10
Accepted
2019-10-10 21:44:34
Documents
1
Period of Report
2019-10-07

Document Format Files

Seq Description Document Type Size
1 FORM 4/A SUBMISSION doc4a.html 4/A  
1 FORM 4/A SUBMISSION doc4a.xml 4/A 4330
  Complete submission text file 0000899243-19-025494.txt   5821
Mailing Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660
Business Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660 360-980-8524
CytoDyn Inc. (Issuer) CIK: 0001175680 (see all company filings)

EIN.: 753056237 | State of Incorp.: DE | Fiscal Year End: 0531
SIC: 2834 Pharmaceutical Preparations

Mailing Address 14 BAYBURY COURT EAST HANOVER NJ 07936
Business Address
Ray Nitya G. (Reporting) CIK: 0001709522 (see all company filings)

Type: 4/A | Act: 34 | File No.: 000-49908 | Film No.: 191146965